← Back to catalogue

LIAISON QuantiFERON-TB Gold Plus Assay

FDA PMA

Class III (US FDA PMA)

PMA P180047

by Diasorin Inc.

Identity

Trade Name
LIAISON QuantiFERON - TB Gold Plus, LIAISON Control QuantiFERON - TB Gold Plus and LIAISON QuantiFERON Software FDA PMA
Generic Name
TEST, IMMUNITY, CELL MEDIATED, MYCOBACTERIUM TUBERCULOSIS FDA PMA

Identifiers

PMA Number
P180047 FDA PMA
FDA Product Code
NCD FDA PMA

Classification

Device Class
Class III FDA PMA
Advisory Committee
Microbiology FDA PMA
FDA Decision
APPR Approved FDA PMA

The LIAISON QuantiFERON-TB Gold Plus Assay is an in vitro diagnostic test classified as a cell-mediated immunity test for Mycobacterium tuberculosis. It detects interferon-gamma (IFN-γ) in human lithium heparin plasma via chemiluminescence immunoassay (CLIA) using the LIAISON XL Analyzer, enabling qualitative assessment of Mycobacterium tuberculosis infection, including latent and active disease states. The assay employs QIAGEN QuantiFERON-TB Gold Plus Blood Collection Tubes containing peptide cocktails to stimulate whole blood samples, facilitating detection of antigen-specific immune responses.

The assay is performed exclusively on the LIAISON XL Analyzer and requires the use of QIAGEN QuantiFERON-TB Gold Plus Blood Collection Tubes. It is supplied as a single-use diagnostic kit, with results reported as positive, negative, or indeterminate via the optional LIAISON QuantiFERON Software. The LIAISON Control QuantiFERON-TB Gold Plus serves as a quality control sample, validated solely for use with the LIAISON XL Analyzer. Approved under FDA PMA (P180047), the device is intended for clinical use in conjunction with other diagnostic evaluations to aid patient management decisions.

This description and any FAQs above were generated automatically from registry data and have not been verified by the manufacturer or by deviCERTS. Always check the official registry entry and the manufacturer's instructions for use before relying on them.

Authorization Coverage (1 country)

Regulatory Authorizations

United States Active

FDA_PMA

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Manufacturer
Diasorin Inc.
FDA Applicant
DiaSorin, Inc.

Sources (1)

  • FDA PMA P180047 24 fields · synced Sep 18, 2026